• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌:流行病学、危险因素与筛查

Cervical cancer: Epidemiology, risk factors and screening.

作者信息

Zhang Shaokai, Xu Huifang, Zhang Luyao, Qiao Youlin

机构信息

Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China.

Department of Epidemiology, National Cancer Center, Chinese Academy of Medical Sciences, School of Population Medicine and Public Health, Peking Union Medical College, Beijing 100021, China.

出版信息

Chin J Cancer Res. 2020 Dec 31;32(6):720-728. doi: 10.21147/j.issn.1000-9604.2020.06.05.

DOI:10.21147/j.issn.1000-9604.2020.06.05
PMID:33446995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797226/
Abstract

Cervical cancer is one of the leading causes of cancer death among females worldwide and its behavior epidemiologically likes a venereal disease of low infectiousness. Early age at first intercourse and multiple sexual partners have been shown to exert strong effects on risk. The wide differences in the incidence among different countries also influenced by the introduction of screening. Although the general picture remains one of decreasing incidence and mortality, there are signs of an increasing cervical cancer risk probably due to changes in sexual behavior. Smoking and human papillomavirus (HPV) 16/18 are currently important issues in a concept of multifactorial, stepwise carcinogenesis at the cervix uteri. Therefore, society-based preventive and control measures, screening activities and HPV vaccination are recommended. Cervical cancer screening methods have evolved from cell morphology observation to molecular testing. High-risk HPV genotyping and liquid-based cytology are common methods which have been widely recommended and used worldwide. In future, accurate, cheap, fast and easy-to-use methods would be more popular. Artificial intelligence also shows to be promising in cervical cancer screening by integrating image recognition with big data technology. Meanwhile, China has achieved numerous breakthroughs in cervical cancer prevention and control which could be a great demonstration for other developing and resource-limited areas. In conclusion, although cervical cancer threatens female health, it could be the first cancer that would be eliminated by human beings with comprehensive preventive and control strategy.

摘要

宫颈癌是全球女性癌症死亡的主要原因之一,其流行病学行为类似于传染性较低的性病。首次性交年龄早和多个性伴侣已被证明对风险有很大影响。不同国家发病率的巨大差异也受到筛查引入的影响。尽管总体情况仍然是发病率和死亡率下降,但由于性行为的变化,宫颈癌风险有增加的迹象。吸烟和人乳头瘤病毒(HPV)16/18目前是子宫颈多因素、逐步致癌概念中的重要问题。因此,建议采取基于社会的预防和控制措施、筛查活动以及HPV疫苗接种。宫颈癌筛查方法已从细胞形态观察发展到分子检测。高危HPV基因分型和液基细胞学是常见方法,已在全球范围内广泛推荐和使用。未来,准确、廉价、快速且易于使用的方法将更受欢迎。人工智能通过将图像识别与大数据技术相结合,在宫颈癌筛查中也显示出前景。同时,中国在宫颈癌防治方面取得了众多突破,可为其他发展中及资源有限地区提供很好的示范。总之,尽管宫颈癌威胁女性健康,但它可能是人类通过综合防治策略能够消除的第一种癌症。

相似文献

1
Cervical cancer: Epidemiology, risk factors and screening.宫颈癌:流行病学、危险因素与筛查
Chin J Cancer Res. 2020 Dec 31;32(6):720-728. doi: 10.21147/j.issn.1000-9604.2020.06.05.
2
[Epidemiology of cervix cancer--a review].[宫颈癌流行病学——综述]
Arch Geschwulstforsch. 1987;57(5):401-16.
3
Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.四价人乳头瘤病毒疫苗在墨西哥的成本效益分析。
Arch Med Res. 2009 Aug;40(6):503-13. doi: 10.1016/j.arcmed.2009.08.004.
4
Epidemiology of cancer of the cervix: global and national perspective.子宫颈癌流行病学:全球及国家视角
J Indian Med Assoc. 2000 Feb;98(2):49-52.
5
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.在未接种 HPV 疫苗且 HPV 阴性的老年女性中,最后一次筛查的年龄与宫颈癌剩余终生风险:一项建模研究。
Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Epub 2018 Nov 1.
6
Risk factors for cervical cancer in Colombia and Spain.哥伦比亚和西班牙宫颈癌的风险因素。
Int J Cancer. 1992 Nov 11;52(5):750-8. doi: 10.1002/ijc.2910520514.
7
Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.牙买加性病门诊就诊者中人乳头瘤病毒的流行情况:年龄较小与性活动增加之间的关联。
Sex Transm Dis. 1995 Mar-Apr;22(2):114-8. doi: 10.1097/00007435-199503000-00007.
8
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.流行病学证据表明,人乳头瘤病毒感染会导致大多数宫颈上皮内瘤变。
J Natl Cancer Inst. 1993 Jun 16;85(12):958-64. doi: 10.1093/jnci/85.12.958.
9
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架:建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
10
High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.高危型 HPV 感染的流行情况及其相关影响因素:一项基于人群的研究,对象为参加 HPV 筛查和宫颈癌早期检测项目的 ISSSTE 受益女性。
BMC Cancer. 2019 Dec 10;19(1):1205. doi: 10.1186/s12885-019-6388-4.

引用本文的文献

1
Prevalence of human papillomavirus (HPV) genotypes among outpatients referred to five laboratories in Shiraz, Iran.伊朗设拉子五家实验室转诊的门诊患者中人乳头瘤病毒(HPV)基因型的流行情况。
Mol Biol Rep. 2025 Sep 11;52(1):896. doi: 10.1007/s11033-025-11002-3.
2
Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis.白藜芦醇:使CD44 + 宫颈癌细胞对卡铂敏感并减轻转移
Cancer Med. 2025 Sep;14(17):e71194. doi: 10.1002/cam4.71194.
3
Emerging nanotherapeutics for HPV-associated cancers: current advances, challenges, and future directions.用于人乳头瘤病毒相关癌症的新型纳米疗法:当前进展、挑战及未来方向
Discov Oncol. 2025 Aug 29;16(1):1653. doi: 10.1007/s12672-025-02439-w.
4
Screening for Cervical Cancer and Early Treatment (SCCET) Project-The Programmatic Data of Romanian Experience in Primary Screening for High-Risk HPV DNA.宫颈癌筛查与早期治疗(SCCET)项目——罗马尼亚高危型人乳头瘤病毒DNA初筛经验的项目数据
Diagnostics (Basel). 2025 Aug 18;15(16):2066. doi: 10.3390/diagnostics15162066.
5
Clinical profile and immediate outcomes of concurrent chemoradiation for cervical cancer at the Bugando medical centre in Mwanza, Tanzania.坦桑尼亚姆万扎布甘多医疗中心宫颈癌同步放化疗的临床特征及近期疗效
Afr Health Sci. 2025 Jun;25(2):218-226. doi: 10.4314/ahs.v25i2.27.
6
Primary analysis of malignant neoplasm trends and demographics in hospitalized patients in Kashi prefecture from 2016 to 2023.2016年至2023年喀什地区住院患者恶性肿瘤趋势及人口统计学初步分析
BMC Cancer. 2025 Aug 20;25(1):1345. doi: 10.1186/s12885-025-14783-9.
7
Factors influencing utilisation of cervical cancer screening services among HIV positive women attending care and treatment centres in Kinondoni municipality, Dar es Salaam, Tanzania.影响坦桑尼亚达累斯萨拉姆基农多尼市接受护理和治疗中心治疗的艾滋病毒阳性女性宫颈癌筛查服务利用率的因素。
Afr Health Sci. 2024 Jun;24(2):32-40. doi: 10.4314/ahs.v24i2.5.
8
Comparison of the SureX HPV genotyping test with the Digene Hybrid Capture 2 test in cervical cancer screening.SureX HPV基因分型检测与Digene杂交捕获2检测在宫颈癌筛查中的比较。
Front Oncol. 2025 Jul 24;15:1627935. doi: 10.3389/fonc.2025.1627935. eCollection 2025.
9
Enterocutaneous Fistula: A Challenging Complication in Cervical Cancer Management.肠皮肤瘘:宫颈癌治疗中的一个具有挑战性的并发症。
Cureus. 2025 Jul 7;17(7):e87475. doi: 10.7759/cureus.87475. eCollection 2025 Jul.
10
Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects.丁香酚:抗癌前景与药理学方面的洞察
Food Sci Nutr. 2025 Aug 3;13(8):e70727. doi: 10.1002/fsn3.70727. eCollection 2025 Aug.

本文引用的文献

1
Estimates of the global burden of cervical cancer associated with HIV.与 HIV 相关的宫颈癌全球负担估计。
Lancet Glob Health. 2021 Feb;9(2):e161-e169. doi: 10.1016/S2214-109X(20)30459-9. Epub 2020 Nov 16.
2
HPV post-infection microenvironment and cervical cancer.HPV 感染后微环境与宫颈癌。
Cancer Lett. 2021 Jan 28;497:243-254. doi: 10.1016/j.canlet.2020.10.034. Epub 2020 Oct 27.
3
Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.人工智能辅助细胞学检测宫颈上皮内瘤变或浸润性癌:一项多中心、基于临床的观察性研究。
Gynecol Oncol. 2020 Oct;159(1):171-178. doi: 10.1016/j.ygyno.2020.07.099. Epub 2020 Aug 16.
4
The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.人工智能辅助细胞学诊断系统在大规模宫颈癌筛查中的应用:一项基于人群的 70 万名妇女的队列研究。
Cancer Med. 2020 Sep;9(18):6896-6906. doi: 10.1002/cam4.3296. Epub 2020 Jul 22.
5
Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology.评价一种甲基化分类器,用于预测 HPV16/18 和细胞学检查结果异常的女性中的癌前病变。
Clin Epigenetics. 2020 Apr 21;12(1):57. doi: 10.1186/s13148-020-00849-x.
6
Commercially available molecular tests for human papillomaviruses: a global overview.市售人乳头瘤病毒分子检测:全球概览。
Clin Microbiol Infect. 2020 Sep;26(9):1144-1150. doi: 10.1016/j.cmi.2020.03.033. Epub 2020 Apr 2.
7
Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis.口服避孕药的使用与宫颈癌风险:系统评价与荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2020 Apr;247:163-175. doi: 10.1016/j.ejogrb.2020.02.014. Epub 2020 Feb 21.
8
Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD).癌症统计数据:世界卫生组织(WHO)与全球疾病负担(GBD)之间的比较。
Eur J Public Health. 2020 Oct 1;30(5):1026-1027. doi: 10.1093/eurpub/ckz216.
9
Cervical cancer prevention in China: a key to cancer control.中国的宫颈癌预防:癌症控制的关键
Lancet. 2019 Mar 9;393(10175):969-970. doi: 10.1016/S0140-6736(18)32849-6.
10
[Elimination of cervical cancer in Latin America].[拉丁美洲的宫颈癌消除]
Salud Publica Mex. 2018 Nov-Dic;60(6):621-623. doi: 10.21149/10170.